Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited18.0487561678.9603
Domestic EquitiesDivi's Laboratories Limited8.213967394.0778
Domestic EquitiesCipla Limited7.9591298443.9513
Domestic EquitiesDr. Reddys Laboratories Limited7.9311323243.9374
Domestic EquitiesApollo Hospitals Enterprise Limited7.655254603.8004
Domestic EquitiesMax Healthcare Institute Limited7.6026394473.7743
Domestic EquitiesLupin Limited5.5762128592.7683
Domestic EquitiesFortis Healthcare Limited4.7411276422.3537
Domestic EquitiesTorrent Pharmaceuticals Limited4.425655472.1971
Domestic EquitiesLaurus Labs Limited4.0060206091.9888
Domestic EquitiesAurobindo Pharma Limited3.6090148361.7917
Domestic EquitiesAlkem Laboratories Limited3.548631031.7617
Domestic EquitiesGlenmark Pharmaceuticals Limited3.243279871.6101
Domestic EquitiesBiocon Limited2.7971378571.3886
Domestic EquitiesMankind Pharma Ltd2.566659991.2742
Domestic EquitiesZydus Lifesciences Limited2.3670132731.1751
Domestic EquitiesIPCA Laboratories Limited2.184173721.0843
Domestic EquitiesAbbott India Limited1.53252760.7608
Domestic EquitiesPiramal Pharma Ltd1.0227328210.5077
Domestic EquitiesSyngene International Limited0.9596100630.4764
Total 99.9899 49.6400
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited0.0403 0.0200
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.0302 -0.0150
Total 0.0101 0.0050
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.